Transcat, Inc. (NASDAQ:TRNS) Stake Raised by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its holdings in Transcat, Inc. (NASDAQ:TRNS) by 1.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 75,700 shares of the scientific and technical instruments company’s stock after purchasing an additional 868 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Transcat were worth $8,005,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Champlain Investment Partners LLC boosted its position in Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after acquiring an additional 74,169 shares during the period. Geode Capital Management LLC raised its stake in shares of Transcat by 5.4% during the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after purchasing an additional 11,106 shares in the last quarter. State Street Corp lifted its holdings in Transcat by 8.1% in the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after purchasing an additional 15,514 shares during the period. Catawba River Capital lifted its holdings in Transcat by 2.2% in the fourth quarter. Catawba River Capital now owns 67,300 shares of the scientific and technical instruments company’s stock worth $7,116,000 after purchasing an additional 1,473 shares during the period. Finally, Needham Investment Management LLC grew its position in Transcat by 43.6% in the 3rd quarter. Needham Investment Management LLC now owns 39,500 shares of the scientific and technical instruments company’s stock valued at $4,770,000 after buying an additional 12,000 shares in the last quarter. 98.34% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on TRNS shares. Oppenheimer lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. Northland Securities reaffirmed a “market perform” rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. HC Wainwright lowered their price target on Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Finally, Craig Hallum upped their price objective on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $111.50.

Transcat Stock Down 1.3 %

TRNS stock opened at $69.07 on Monday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The firm has a market cap of $642.97 million, a PE ratio of 37.34 and a beta of 0.66. Transcat, Inc. has a 12 month low of $67.56 and a 12 month high of $147.12. The firm has a 50 day simple moving average of $82.92 and a 200 day simple moving average of $102.43.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter in the prior year, the firm posted $0.56 earnings per share. Equities research analysts forecast that Transcat, Inc. will post 2.3 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Craig D. Cairns bought 1,200 shares of the company’s stock in a transaction dated Friday, January 31st. The shares were acquired at an average cost of $77.02 per share, with a total value of $92,424.00. Following the completion of the transaction, the director now directly owns 1,910 shares in the company, valued at approximately $147,108.20. The trade was a 169.01 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 2.30% of the stock is currently owned by company insiders.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.